🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Neuritis

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging NCT07202494n/a1 site📍 Marseille Assistance Publique Hopitaux De Marseille · Tests: Imaging Techniques (MRI 3T & 7T, Functional, Structural, and Metabolic Imaging) Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD NCT06780709NA1 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Wellness Program and Behavioral Counseling Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes. NCT06615622n/a1 site📍 Asyut Assiut University · Tests: Placebo Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD) NCT05145361EARLY Phase 14 sites📍 Beijing📍 Taiyuan📍 Xi’an Shanghai Pharmaceuticals Holding Co., Ltd · Tests: B001 injection, Placebo Short Duration Electrical Stimulation to Improve Outcomes After Cubital Tunnel Release (SELECT) Trial NCT05980767NA2 sites📍 Hamilton📍 Hamilton Epineuron Technologies Inc. · Tests: Temporary Peripheral Nerve Stimulation System A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD) NCT06413654Phase 2, Phase 351 sites📍 Beijing📍 Beijing📍 Beijing Shanghai Jiaolian Drug Research and Development Co., Ltd · Tests: B001, Placebo Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection NCT07555431Phase 21 site📍 Salvador Carlos Brites · Tests: Combination of Dolutegravir + Tenofovir DF for treatment of HTLV-1 infection, Dolutegravir (DTG) Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study NCT07410039Phase 41 site📍 Beijing Chinese PLA General Hospital · Tests: Eculizumab+IVMP, IVIG+IVMP, IVMP Early Feasibility of the Nervonik Peripheral Nerve Stimulation Device NCT06772142EARLY Phase 11 site📍 Panama City Nervonik · Tests: Peripheral Nerve Stimulation Feasibility and Clinical Utility of Paired Non-Invasive Hemodynamic and Tissue Oximetry Monitoring to Detect Limb Ischemia in Lithotomy-Positioned Surgeries NCT07387653n/a2 sites📍 Houston📍 Houston The University of Texas Health Science Center, Houston · Tests: Lower-Extremity Perfusion Monitoring VIsual Pathways Model in Neuro-inflammatory Disorders NCT05487989n/a1 site📍 Lille University Hospital, Lille · Tests: Clinical examen Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER) NCT02521311Phase 21 site📍 San Francisco University of California, San Francisco · Tests: Clemastine, Placebo Ofatumumab in AQP4-IgG Seropositive NMOSD NCT05504694Phase 1, Phase 21 site📍 Xi'an Tang-Du Hospital · Tests: Ofatumumab Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases NCT07085676Phase 11 site📍 Jerusalem Polina Stepensky · Tests: HBI0101 CART Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis NCT03401879NA1 site📍 Vienna Medical University of Vienna · Tests: Dynamic Vessel Analyzer (DVA), Fourier Domain Doppler Optical Coherence Tomography (FDOCT), Optical coherence tomograph… Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE) NCT04106830n/a1 site📍 Beijing Beijing Tiantan Hospital · Tests: Intravenous steroid HANDLE-a Real World Study on Satralizumab in NMOSD NCT06829524n/a1 site📍 Shanghai Huashan Hospital · Tests: Satralizumab Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD) NCT07557420Phase 310 sites📍 Beijing📍 Beijing📍 Chengdu Alexion Pharmaceuticals, Inc. · Tests: Ravulizumab Study of Ultomiris® (Ravulizumab) Safety in Pregnancy NCT06312644n/a7 sites📍 Boston📍 Melbourne📍 Paris Alexion Pharmaceuticals, Inc. · Tests: Ultomiris MS-ResearchBiomarkerS NCT05204459n/a1 site📍 Los Angeles Cedars-Sinai Medical Center A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD NCT07762872n/a1 site📍 Beijing Junwei Hao, MD · Tests: Satralizumab Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies NCT05966467n/a33 sites📍 Washington D.C.📍 Boston📍 Chapel Hill Alexion Pharmaceuticals, Inc. Biomarkers in Autoimmune Disease of Nervous System NCT06502015n/a1 site📍 Wuhan Tongji Hospital · Tests: biomaker levels Cohort Study on Neuroimmune Diseases in the Reproductive Age NCT07653984n/a1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy NCT05909761n/a1 site📍 Aurora Amgen · Tests: UPLIZNA Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder NCT07420296Phase 31 site📍 Tianjin Tianjin Medical University General Hospital · Tests: Eculizumab administration, High-dose corticosteroid pulse therapy, Plasma exchange (PE) Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients NCT07427537NA1 site📍 Clermont-Ferrand University Hospital, Clermont-Ferrand · Tests: Assessment of blood concentrations of microRNAs, Chemotherapy-induced peripheral neuropathy (CIPN) - grade, Pain assess… Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders NCT05982925n/a1 site📍 New York Icahn School of Medicine at Mount Sinai Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases NCT07022197Phase 1, Phase 21 site📍 Tianjin Tianjin Medical University General Hospital · Tests: BAFF-R CART Neuroimmunology Registry and Biobank NCT06958341n/a2 sites📍 Berlin📍 Ulm Charite University, Berlin, Germany
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy